Publications by authors named "M Barabino"
Article Synopsis
- * A study involving nearly 2,000 non-resectable HCC patients showed that LMWA had comparable safety and overall survival rates to PRFA and significantly better survival rates than TACE after 1, 3, and 5 years.
- * The results suggest that LMWA is a viable treatment option for early HCC, outperforming TACE while demonstrating similar efficacy to PRFA, which supports its potential inclusion in standardized treatment
Article Synopsis
- An inflammatory pseudotumor of the liver is a rare lesion that resembles cancer but is caused by inflammation, with no known cause and vague symptoms making diagnosis difficult.
- Research involving 69 cases indicates that imaging is often non-specific and biopsies are not commonly performed, despite their importance for diagnosis.
- Current treatment trends lean towards conservative management, but surgical intervention is still the preferred option for uncertain diagnoses, highlighting the need for a collaborative approach in treatment planning.
Gallbladder cancer (GBC) is a rare disease with a poor prognosis. Simple cholecystectomy may be an adequate treatment only for very early disease (Tis, T1a), whereas reoperation is recommended for more advanced disease (T1b and T2). Radical cholecystectomy should have two fundamental objectives: To radically resect the liver parenchyma and to achieve adequate clearance of the lymph nodes.
View Article and Find Full Text PDFBackground: The European Association of Endoscopic Surgery (EAES) recommends, with strong evidence, the use of indocyanine green (ICG) fluorescence imaging combined with intraoperative ultrasound (IOUS) to improve identification of superficial liver tumors. This study reports the use of ICG for the detection of colorectal liver metastases (CRLMs) during minimally invasive liver resection.
Methods: A single-center consecutive series of minimally invasive (laparoscopic and robotic) hepatic resections for CRLMs was prospectively evaluated (April 2019 and October 2023).